CN100340220C - Method for planting esoderma/endothelial cell on inner surface of artificial blood vessel - Google Patents
Method for planting esoderma/endothelial cell on inner surface of artificial blood vessel Download PDFInfo
- Publication number
- CN100340220C CN100340220C CNB2004100218756A CN200410021875A CN100340220C CN 100340220 C CN100340220 C CN 100340220C CN B2004100218756 A CNB2004100218756 A CN B2004100218756A CN 200410021875 A CN200410021875 A CN 200410021875A CN 100340220 C CN100340220 C CN 100340220C
- Authority
- CN
- China
- Prior art keywords
- endothelial
- cells
- shear stress
- artificial blood
- blood vessels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000002889 endothelial cell Anatomy 0.000 title claims abstract description 125
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 82
- 239000002473 artificial blood Substances 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 42
- 210000004027 cell Anatomy 0.000 claims abstract description 79
- 239000012530 fluid Substances 0.000 claims abstract description 33
- 230000003511 endothelial effect Effects 0.000 claims abstract description 25
- 238000011081 inoculation Methods 0.000 claims description 13
- 238000001727 in vivo Methods 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 8
- 230000010349 pulsation Effects 0.000 claims description 5
- 239000006285 cell suspension Substances 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims 1
- 230000009471 action Effects 0.000 abstract description 15
- 230000017531 blood circulation Effects 0.000 abstract description 15
- 238000000338 in vitro Methods 0.000 abstract description 11
- 239000012620 biological material Substances 0.000 abstract description 5
- 230000002792 vascular Effects 0.000 description 37
- 239000000463 material Substances 0.000 description 24
- 210000001715 carotid artery Anatomy 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 12
- 210000003606 umbilical vein Anatomy 0.000 description 12
- 210000003556 vascular endothelial cell Anatomy 0.000 description 12
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 11
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 10
- 208000007536 Thrombosis Diseases 0.000 description 9
- 210000003518 stress fiber Anatomy 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 241000700157 Rattus norvegicus Species 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 7
- 239000004814 polyurethane Substances 0.000 description 7
- 102100037362 Fibronectin Human genes 0.000 description 6
- 108010067306 Fibronectins Proteins 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 6
- 108090000631 Trypsin Proteins 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000002356 single layer Substances 0.000 description 6
- 239000012588 trypsin Substances 0.000 description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
- 210000004618 arterial endothelial cell Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 210000003632 microfilament Anatomy 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- 238000002054 transplantation Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
- 108010031318 Vitronectin Proteins 0.000 description 4
- 102100035140 Vitronectin Human genes 0.000 description 4
- 230000021164 cell adhesion Effects 0.000 description 4
- 210000002744 extracellular matrix Anatomy 0.000 description 4
- 210000001147 pulmonary artery Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 210000001105 femoral artery Anatomy 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 210000004731 jugular vein Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical group NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 229920004934 Dacron® Polymers 0.000 description 2
- -1 FG) Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 101100015391 Mus musculus Ralgds gene Proteins 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 210000004292 cytoskeleton Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000066 endothelium dependent relaxing factor Substances 0.000 description 2
- 230000006862 enzymatic digestion Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 description 2
- 210000004026 tunica intima Anatomy 0.000 description 2
- PJRSUKFWFKUDTH-JWDJOUOUSA-N (2s)-6-amino-2-[[2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[(2-aminoacetyl)amino]-4-methylsulfanylbutanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]propanoyl Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O PJRSUKFWFKUDTH-JWDJOUOUSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102400000686 Endothelin-1 Human genes 0.000 description 1
- 101800004490 Endothelin-1 Proteins 0.000 description 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
- 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 102000003940 Occludin Human genes 0.000 description 1
- 108090000304 Occludin Proteins 0.000 description 1
- 241001111421 Pannus Species 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 102100023132 Transcription factor Jun Human genes 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 208000024248 Vascular System injury Diseases 0.000 description 1
- 208000012339 Vascular injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000025611 cell-substrate adhesion Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 238000003234 fluorescent labeling method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 230000000260 hypercholesteremic effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 108010021753 peptide-Gly-Leu-amide Proteins 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Images
Landscapes
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明提供了一种在人工血管内表面种植内皮/内皮样细胞的方法,采用生物力学的方法,通过体外的脉动的、阶梯式增加的流体剪应力作用,使内皮细胞更好地粘附在人工血管内壁,使粘附在人工血管内壁上的内皮细胞预先适应流体剪应力的作用,使得它在血管移植入体内后有更好的耐受血流剪应力作用的能力。利用该方法可以在各种材料来源的人工血管表面种植内皮细胞,包括合成生物材料、天然生物材料,制备人工血管。
The present invention provides a method for planting endothelial/endothelial-like cells on the inner surface of an artificial blood vessel. By adopting a biomechanical method, the endothelial cells can better adhere to the artificial blood vessel through the action of pulsating and stepwise increased fluid shear stress in vitro. The inner wall of the artificial blood vessel enables the endothelial cells adhering to the inner wall of the artificial blood vessel to adapt to the action of fluid shear stress in advance, so that it has a better ability to withstand the action of blood flow shear stress after the blood vessel is transplanted into the body. The method can be used to plant endothelial cells on the surface of artificial blood vessels from various sources, including synthetic biological materials and natural biological materials, to prepare artificial blood vessels.
Description
技术领域technical field
本发明涉及一种在人工血管内表面种植内皮/内皮样细胞的方法。The invention relates to a method for planting endothelial/endothelial-like cells on the inner surface of artificial blood vessels.
背景技术Background technique
心血管系统疾病是世界上发病率最高的疾病之一,也是目前占主导地位的死亡原因,其主要的治疗手段就是血管移植术。每一年仅在美国就要进行超过570,000的冠状动脉旁路血管移植手术,另外血管旁路手术的实施也需要大量的外周血管的移植。由此导致了对小口径(<6mm)血管移植物的大量需求。Cardiovascular system disease is one of the diseases with the highest incidence rate in the world, and it is also the leading cause of death at present. The main treatment method is vascular transplantation. Every year in the United States alone, more than 570,000 coronary artery bypass grafts are performed. In addition, the implementation of bypass surgery also requires a large number of peripheral vascular grafts. This has resulted in a significant demand for small caliber (<6 mm) vascular grafts.
而血管组织工程学的目的就是在体外构建理想的血管移植物,移植后无免疫排斥反应,能维持移植血管腔的长期通畅。心血管外科需要各种直径大小的血管移植物作为修补材料。目前直径>6mm的人工血管移植物已经广泛应用于临床,而小口径人工血管移植物大量需求的同时又因阻塞率较高,临床应用明显受到限制。因此导致目前血管组织工程的热点在于制备管径小于6mm的小血管。小血管移植失败的原因,在急性期主要为血栓形成;在慢性期主要为平滑肌细胞向移植物管腔内增生和吻合处血管翳的形成导致管腔阻塞。相对于组织工程血管而言,人体自身血管由于有血管内皮细胞的屏障作用,具有良好的抗血栓形成能力。因此,使人工血管材料成功内皮化是提高小口径人工血管通畅率的希望所在。The purpose of vascular tissue engineering is to construct an ideal vascular graft in vitro, without immune rejection after transplantation, and to maintain the long-term patency of the grafted vessel lumen. Cardiovascular surgery requires vascular grafts of various diameters as repair materials. At present, artificial vascular grafts with a diameter > 6 mm have been widely used in clinical practice, while small-diameter artificial vascular grafts are in great demand and have a high blocking rate, so their clinical application is obviously limited. Therefore, the current focus of vascular tissue engineering is to prepare small blood vessels with a diameter of less than 6mm. The reasons for the failure of small vessel grafts are mainly thrombosis in the acute phase; in the chronic phase, the proliferation of smooth muscle cells into the lumen of the graft and the formation of pannus at the anastomosis lead to lumen obstruction. Compared with tissue-engineered blood vessels, human blood vessels have good anti-thrombosis ability due to the barrier effect of vascular endothelial cells. Therefore, the successful endothelialization of artificial blood vessel materials is the hope of improving the patency rate of small-caliber artificial blood vessels.
1、在人工血管内表面接种内皮/内皮样细胞1. Inoculation of endothelial/endothelial-like cells on the inner surface of artificial blood vessels
通过对血管内皮细胞(VEC)的研究,发现VEC具有高度代谢活性并有内分泌的功能,它能合成和释放多种生理有效物质,对许多生理活动有调节作用,维持体内生理活动的平衡,诸如对血管平滑肌张力、微血管通透性、血小板活性、凝血、抗凝血及纤溶系统等方面的调节。VEC表面同血细胞一样带有负电荷,能阻止血细胞在人造血管腔上的沉积,因此VEC的种植具有抗血小板聚集、防止血液凝固和血栓形成的作用。Through the study of vascular endothelial cells (VEC), it is found that VEC has high metabolic activity and endocrine function. It can synthesize and release a variety of physiologically effective substances, regulate many physiological activities, and maintain the balance of physiological activities in the body, such as Regulation of vascular smooth muscle tension, microvascular permeability, platelet activity, coagulation, anticoagulant and fibrinolytic system. The surface of VEC has the same negative charge as blood cells, which can prevent the deposition of blood cells on the lumen of artificial blood vessels. Therefore, the planting of VEC has the effect of anti-platelet aggregation, preventing blood coagulation and thrombus formation.
1970年由Mansfield首先提出内皮细胞的种植方法,近年众多的研究者也在尝试通过内皮细胞衬里来改善移植物的性能,使移植物能在体内具有更好的仿生能力。1998年,ShinokaT等设计制作了体外自体肺动脉移植血管。取出生后20天的绵羊的颈动脉,采用组织块培养方法获得混和细胞群落,再应用荧光标记法分离平滑肌细胞(SMCs)和内皮细胞(ECs),先后种植于可吸收材料聚乳酸-共乙醇酸(PGLA)上,7天后用体外构建的血管置换原绵羊主肺动脉。移植10~12周后,无明显血栓形成和钙化的迹象,这一工作开创了新型血管移植物研究的先河(Shinoka T,Tim AD,etal.Creation of viable pulmonary artery autograftsthrough tissue engineering.J Thorac Cardiovasc Surg.1998,115:536-546.题目为:采用组织工程方法开发活的肺动脉自体移植物)。In 1970, Mansfield first proposed the implantation method of endothelial cells. In recent years, many researchers are also trying to improve the performance of grafts through the lining of endothelial cells, so that the grafts can have better bionic capabilities in vivo. In 1998, ShinokaT et al. designed and produced in vitro autologous pulmonary artery grafts. The carotid artery of a 20-day-old sheep was taken out, and the mixed cell community was obtained by tissue block culture method, and then the smooth muscle cells (SMCs) and endothelial cells (ECs) were separated by the fluorescent labeling method, and planted in the absorbable material polylactic acid-coethanol successively acid (PGLA), the original sheep main pulmonary artery was replaced with an in vitro constructed vessel after 7 days. After 10-12 weeks of transplantation, there were no obvious signs of thrombus formation and calcification. This work created a precedent for the study of new vascular grafts (Shinoka T, Tim AD, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg .1998, 115:536-546. Title: Development of Living Pulmonary Artery Autografts Using Tissue Engineering Approaches).
近来陆续有关于自体EC移植促进损伤内皮修复的报道。Conte等使用兔股动脉球囊损伤模型,阻断股动脉两端血流后,将转染β-半乳糖苷酶基因的自体颈静脉EC注入内皮剥脱血管段,发现自体颈静脉EC移植能有效抑制高胆固醇血症兔球囊成形术后再狭窄。Darcin等运用狗股动脉球囊损伤模型,将自体颈静脉EC移植到内皮剥脱血管段,实验结果显示此种方法也能明显改善损伤血管的长期通畅率。Recently, it has been reported that autologous EC transplantation can promote the repair of damaged endothelium. Conte et al. used a rabbit femoral artery balloon injury model, blocked the blood flow at both ends of the femoral artery, injected autologous jugular vein EC transfected with β-galactosidase gene into the endothelial stripped vessel segment, and found that autologous jugular vein EC transplantation can effectively Inhibition of restenosis after balloon angioplasty in hypercholesterolemic rabbits. Darcin et al. used a dog femoral artery balloon injury model to transplant autologous jugular vein EC to the endothelialized vessel segment. The experimental results showed that this method could also significantly improve the long-term patency of the injured vessel.
虽然组织工程血管移植物内皮化后在一定程度上改善了血栓形成问题,但是仍然没有解决小口径血管的远期通畅率问题。研究发现对于口径小于6mm的血管移植物EC的低灌注量导致了内皮细胞在移植物上粘附力不够,从而产生了远期通畅率都比较低的后果,因此在衬里技术方面还要进一步改善。早在1994年Herring就指出在膨体聚四氟乙烯(ePTFE)支架材料上种植内皮细胞使支架内皮化的失败,与内膜增生和内腔面血栓的形成相关联,并指出其可能的原因就是支架材料植入体内后材料内腔面的内皮细胞层的缺失。Bhat VD等认为其机制可能就是体内的血液流动减弱了植入体内的细胞的粘附力,使植入的内皮细胞脱落,因此如何提高接种后内皮细胞的粘附能力又成为急需解决的问题。Although the endothelialization of tissue-engineered vascular grafts has improved the thrombosis problem to a certain extent, the problem of long-term patency of small-caliber vessels has not yet been resolved. Studies have found that the low perfusion of EC for vascular grafts with a caliber of less than 6mm leads to insufficient adhesion of endothelial cells on the graft, resulting in a low long-term patency rate, so further improvement is needed in the lining technology . As early as 1994, Herring pointed out that the failure of planting endothelial cells on the expanded polytetrafluoroethylene (ePTFE) scaffold material to endothelialize the scaffold was associated with intimal hyperplasia and the formation of lumen thrombus, and pointed out the possible reasons It is the absence of the endothelial cell layer on the inner surface of the material after the scaffold material is implanted in the body. Bhat VD et al. believe that the mechanism may be that the blood flow in the body weakens the adhesion of implanted cells and makes the implanted endothelial cells fall off. Therefore, how to improve the adhesion of endothelial cells after inoculation has become an urgent problem to be solved.
2、提高内皮/内皮样细胞在血管壁上的粘附性2. Improve the adhesion of endothelial/endothelial-like cells on the vessel wall
人工血管能否内皮化,取决于种植细胞在人工血管壁上粘附、生长和扩展的能力。一方面可以通过高密度种植内皮细胞,在血管移植物内表面形成一层牢固的融合细胞。另一方面则要保证移植物植入体内后,种植细胞在血流作用下仍能附着于管壁上。研究者发现体外粘附于移植物上的VEC在体内剪应力场中很容易脱落,即发现内皮细胞粘附不牢固,组织工程血管的远期通畅和血栓形成的问题仍然没有得到解决,由此提出了各种提高EC在移植物表面粘附力的方法,主要有:Whether the artificial blood vessel can be endothelialized depends on the ability of the implanted cells to adhere, grow and expand on the wall of the artificial blood vessel. On the one hand, endothelial cells can be planted at a high density to form a solid layer of fusion cells on the inner surface of the vascular graft. On the other hand, it is necessary to ensure that after the graft is implanted in the body, the planting cells can still adhere to the vessel wall under the action of blood flow. The researchers found that the VEC adhered to the graft in vitro is easy to fall off in the shear stress field in vivo, that is, the adhesion of endothelial cells is found to be weak, and the problems of long-term patency and thrombus formation of tissue engineered blood vessels have not been resolved. Various methods have been proposed to improve the adhesion of EC on the graft surface, the main ones are:
(1)在人工血管壁上预衬细胞外基质(ECM)蛋白:如纤维连接蛋白(fibronectin,FN)、纤维蛋白原(fibrinogen,FG)、玻璃体连接蛋白(vitronectin,VN)、层粘连蛋白(laminin,La)和胶原蛋白(collagen,CL)等。FN、FG和VN结构中排列的精氨酸-甘氨酸-天门冬氨酸-丝氨酸(RGDs)为主要的细胞粘附决定簇。RGDs具有特异性识别功能,可与内皮细胞膜上一个跨膜的蛋白家族——整合素家族(Integrinsfamily,IF)特异结合,从而能粘附内皮细胞。鉴于此,一些研究小组直接在人工血管壁上附以RGD肽链加以修饰,或者在人工血管壁上固定包含RGD的多肽,可促进内皮细胞的粘附。(1) Pre-line extracellular matrix (ECM) proteins on the artificial blood vessel wall: such as fibronectin (FN), fibrinogen (fibrinogen, FG), vitronectin (VN), laminin ( laminin, La) and collagen (collagen, CL), etc. Arginine-glycine-aspartate-serine (RGDs) arranged in the structures of FN, FG and VN are major cell adhesion determinants. RGDs have a specific recognition function, and can specifically combine with a transmembrane protein family on the endothelial cell membrane - Integrins family (IF), so that they can adhere to endothelial cells. In view of this, some research groups directly attach RGD peptide chains to the artificial blood vessel wall for modification, or immobilize RGD-containing polypeptides on the artificial blood vessel wall, which can promote the adhesion of endothelial cells.
(2)利用生物素(biotin)与抗生物素蛋白(avidin)的特异结合力而增加内皮细胞的粘附:将培养的内皮细胞经生物素处理,而在人工血管内壁衬以抗生物素蛋白,利用他们的特异亲合力,可以明显增强内皮细胞在人工血管壁上的粘附与抗切应力的能力。(2) Use the specific binding force of biotin and avidin to increase the adhesion of endothelial cells: the cultured endothelial cells are treated with biotin, and the inner wall of the artificial blood vessel is lined with avidin , using their specific affinity, can obviously enhance the adhesion of endothelial cells on the wall of artificial blood vessels and the ability to resist shear stress.
(3)利用细胞生长因子的作用,提高内皮细胞的粘附与生长能力:如利用成纤维细胞生长因子(fibroblast growth factor,FGF)与肝素有高亲合力位点,而肝素的缓慢释放可以抑制平滑肌增殖的特点,在肝素-白蛋白预衬的人工血管壁中加入FGF,也有助于内皮细胞的生长和粘附。(3) Use the action of cell growth factors to improve the adhesion and growth ability of endothelial cells: for example, using fibroblast growth factor (fibroblast growth factor, FGF) has a high affinity site with heparin, and the slow release of heparin can inhibit Characterized by smooth muscle proliferation, the addition of FGF to heparin-albumin-prelined artificial vessel walls also facilitated endothelial cell growth and adhesion.
(4)改变植入内皮细胞的带电性:由于内皮细胞带负电,而人工血管壁(如ePTFE)也带负电,相互间具有排斥作用。可以利用静电作用使植入的内皮细胞带上短时间的正电或少带负电,从而提高内皮细胞在血管壁上的附着能力和抗血流切应力的能力。但负电荷减少的同时又增加了血栓形成的机率。(4) Change the electrification of the implanted endothelial cells: because the endothelial cells are negatively charged, and the artificial blood vessel wall (such as ePTFE) is also negatively charged, they have mutual repulsion. Electrostatic action can be used to charge the implanted endothelial cells positively or less negatively for a short period of time, thereby improving the adhesion ability of endothelial cells on the blood vessel wall and the ability to resist blood flow shear stress. However, the reduction of negative charge increases the probability of thrombus formation.
(5)应用分子生物学技术:现代分子生物学技术的发展,使人们可能对细胞基因进行修饰。因此,在接种的内皮细胞里导入致血管扩张、抗血栓形成的基因片段,就有希望从根本上提高人工血管的通畅率。(5) Application of molecular biology technology: The development of modern molecular biology technology makes it possible to modify cell genes. Therefore, it is hoped to fundamentally improve the patency of artificial blood vessels by introducing gene fragments that induce vasodilation and antithrombosis into the inoculated endothelial cells.
(6)内皮细胞与平滑肌细胞的联合培养:平滑肌细胞(SMC)是血管壁的主要细胞成分。此种细胞能产生多量细胞外基质成分,SMC通过直接或间接的方式影响内皮细胞的形态,从而有利于内皮细胞的附着。(6) Joint culture of endothelial cells and smooth muscle cells: smooth muscle cells (SMC) are the main cell components of the vessel wall. Such cells can produce a large amount of extracellular matrix components, and SMC directly or indirectly affects the morphology of endothelial cells, thereby facilitating the attachment of endothelial cells.
虽然研究者们采用了各种方法来提高内皮细胞的粘附性,但是在血管移植物植入体内后,在长期的血液流场中仍然易发生内皮细胞层的脱落,从而导致血栓的形成。经过长期的探索,人们逐渐认识到内皮细胞是保持血管稳定性的天然调节物。在血管损伤后,血管的内皮细胞单层具有抗血栓形成和平滑肌细胞增生的作用。Shannon L等人指出成功的组织工程血管移植物必须要保证有能够抵抗血流剪切力和血栓形成的内皮细胞单层(Shannon L,Niklason MLE..Requirements for growing tissue-engineered vascular grafts.Cardiovascular Pathology.2003,12:59-64.题目为:对活的组织工程血管移植物的需求)。Although researchers have used various methods to improve the adhesion of endothelial cells, after vascular grafts are implanted in vivo, the endothelial cell layer is still prone to shedding in the long-term blood flow field, resulting in the formation of thrombus. After long-term exploration, people have gradually realized that endothelial cells are natural regulators of blood vessel stability. After vascular injury, the endothelial cell monolayer of blood vessels has antithrombotic and smooth muscle cell proliferation effects. Shannon L et al pointed out that successful tissue-engineered vascular grafts must ensure a monolayer of endothelial cells that can resist blood flow shear force and thrombus formation (Shannon L, Niklason MLE..Requirements for growing tissue-engineered vascular grafts. Cardiovascular Pathology .2003, 12:59-64. Title: The Need for Living Tissue-Engineered Vascular Grafts).
3、流体力学环境对血管内皮细胞的影响:3. The influence of hydrodynamic environment on vascular endothelial cells:
现已知,构建组织工程血管的一大难题在于血管处在一个天然的机械动力环境,它包括:血液流经内皮层的切线作用产生的剪切力(shear stress),环形管壁舒缩产生的牵张应力(stretch stress)和静水压产生的正常应力。剪切力对血管内皮细胞的形态、增殖、极性及基质的构成和结构有着重要的影响。It is now known that a major problem in constructing tissue engineered blood vessels is that the blood vessels are in a natural mechanical dynamic environment, which includes: the shear stress generated by the tangential action of the blood flowing through the endothelial layer, the shrinkage and contraction of the annular vessel wall The stretch stress (stretch stress) and the normal stress caused by hydrostatic pressure. Shear stress has an important effect on the morphology, proliferation, polarity and matrix composition and structure of vascular endothelial cells.
(1)剪切力对内皮细胞(EC)形态的影响:很早以前,人们就注意到在体内条件下血流可影响ECs的形态和排列方向。在单向稳定的高切应力区域ECs呈长梭形,细胞长轴与切应力方向一致。而在低切应力或血液滞留区域,ECs呈圆形,细胞的排列没有定向。体外实验发现人脐静脉血管内皮细胞(HUVECs)被38、75dyne/cm2的流体剪切力作用12小时后,内皮细胞被拉长,长轴与流场方向一致,且内皮细胞的拉长,定向程度与切应力大小、作用时间长短有关(陈槐卿,医用生物力学.2003,18(增刊):3-4.)。最近的研究也证明了无论在体内还是在体外,血流剪切作用内皮细胞,将刺激内皮细胞释放前列环素(Prostacyclin,PGI2)和内皮细胞衍生舒张因子(Endothelium-derived relaxing factor,EDRF)。静态的呈现多边形的内皮细胞直接在血流剪切力作用下逐渐变得细长和定向于流动方向。内皮细胞的形态因切应力的作用而发生的形态重建(腔面呈现流线型的特征),有助于降低血液流动对内皮细胞的牵拉作用,从而保持内皮细胞单层结构的完整性。(1) The effect of shear stress on the morphology of endothelial cells (ECs): It has long been noticed that blood flow can affect the morphology and orientation of ECs under in vivo conditions. In the unidirectional stable high shear stress region, the ECs were long fusiform, and the long axis of the cells was consistent with the direction of the shear stress. In contrast, in areas of low shear stress or blood stagnation, ECs were round and the arrangement of cells was not oriented. In vitro experiments found that after human umbilical vein vascular endothelial cells (HUVECs) were subjected to fluid shear force of 38 and 75 dyne/ cm2 for 12 hours, the endothelial cells were elongated, and the long axis was consistent with the direction of the flow field, and the elongation of endothelial cells, The degree of orientation is related to the magnitude of the shear stress and the duration of the action (Chen Huaiqing, Medical Biomechanics. 2003, 18 (Supplement): 3-4.). Recent studies have also demonstrated that blood flow shears endothelial cells, both in vivo and in vitro, and stimulates endothelial cells to release prostacyclin (PGI 2 ) and endothelium-derived relaxing factor (EDRF) . The static polygonal endothelial cells become elongated and oriented in the direction of flow directly under the shear force of blood flow. The morphological reconstruction of endothelial cells due to the action of shear stress (the cavity surface presents a streamlined feature) helps to reduce the pulling effect of blood flow on endothelial cells, thereby maintaining the integrity of the monolayer structure of endothelial cells.
(2)剪切力对内皮细胞粘附力的影响:研究显示剪切力条件可以提高其作用下细胞的粘附能力,在流动条件下,剪切力逐渐加载于内皮细胞衬里的材料支架,实验发现剪切力的作用促进了细胞支架网络的重建和细胞基底粘附。内径为1.5mm的聚氨酯(polyurethane,Pu)血管种植了EC,通过1-2dyn/cm2的剪切力作用3天,然后再用25dyn/cm2的剪切力再继续作用3天,实验后研究者发现保存了较完整的内皮细胞层,而直接用25dyn/cm2的剪切力作用后只有少量的内皮细胞的存留(Ott MJ,Ballermann BJ.Shear stress-conditioned,endothelial cell-seeded vascular grafts:Improved cell adherence in response to invitro shear stress.Surgery.1995,117:334-339.题目为:剪应力驯化的接种了内皮细胞的血管移植物:体外剪应力的作用增加了细胞粘附)(Dardik A,Liu A,Ballermann B.Chronic in vitro shear stress stimulates endothelial cell retention on prostheticvascular grafts and reduces subsequent in vito neointimal thickness.Journal ofVascular Surgery.1999,29(1):157-167.题目为:长期的体外剪应力作用增加了内皮细胞在人工血管移植物上的滞留率,之后减少了体内新生内膜的厚度)。内径为4mm的绵羊颈动脉(Photofix),通过研究者们控制的剪应力的作用,使得在剪应力值初始值为约0.25dyn/cm2,最终为约1.2dyn/cm2时,作用时间为6小时,内皮细胞在Photofix上的保留面积为50%(Carnagey J,Anderson DH,Ranieri J,et al.Rapid endothelialization ofphotofix natural biomaterial vascular grafts.J Biomed Mater Res Part B:ApplBiomater.2003,65B:.171-179.题目为:photofix天然人工血管的快速内皮化)。虽然这些研究中前者采取的剪应力值有一定的随意性,而且采用的剪应力值的个数很有限,仅包含了1或25dyn/cm2,后者选取的剪应力值很小,与人体正常的剪应力值有较大差异,但是他们的结果暗示了逐渐增加的剪切力能够提高细胞耐受(抵抗)生理水平的流动力。在本发明中采取的是阶梯式(stepwise)的增加的剪应力,更强调剪应力的逐渐增加过程,而涉及到的剪应力值是处于正常人体血管内皮细胞所受的剪应力值范围,研究结果也证实,采用本发明方法使得接种在去除内皮细胞的Wistar大鼠颈动脉上的人脐静脉内皮细胞通过阶梯式增加的,最终高达26dyn/cm2的剪应力作用24小时后,其保留面积为80%以上。2002年李玉泉等报道了40dyn/cm2的稳定层流切应力下,与平滑肌联合培养的内皮细胞的ECM中纤维连接素(fibronectin,Fn)和层粘连蛋白(laminin,Ln)的含量增多,而导致了内皮细胞的粘附能力和抗流体剪应力能力增加。Philippe等人在实验中使用聚乙二醇对苯二甲酸酯(polyethyleneterephthalate,PET)血管(内径6mm),并在内腔面涂布牛胶原和低密度肝素,采用脉动灌注系统培养粘附在移植物上细胞,实验结果也显示长期的灌注和高水平(与血流剪切力相等)的剪切力十分有利于种植内皮细胞的在移植物上的存留。(2) The effect of shear stress on the adhesion of endothelial cells: studies have shown that shear stress conditions can improve the adhesion of cells under its action. Under flow conditions, shear stress is gradually loaded on the material scaffold of the endothelial cell lining, It was found that the effect of shear force promoted the reconstruction of the cell scaffold network and cell-substrate adhesion. ECs were planted in polyurethane (Pu) blood vessels with an inner diameter of 1.5 mm, and subjected to a shear force of 1-2 dyn/cm 2 for 3 days, and then a shear force of 25 dyn/cm 2 for another 3 days. After the experiment The researchers found that a relatively complete endothelial cell layer was preserved, and only a small amount of endothelial cells remained after direct application of a shear force of 25dyn/cm 2 (Ott MJ, Ballermann BJ.Shear stress-conditioned, endothelial cell-seeded vascular grafts : Improved cell adhesion in response to invitro shear stress.Surgery.1995, 117:334-339. Title: Shear stress acclimated vascular grafts inoculated with endothelial cells: The effect of in vitro shear stress increases cell adhesion) (Dardik A, Liu A, Ballermann B. Chronic in vitro shear stress stimulates endothelial cell retention on prosthetic vascular grafts and reduces subsequent in vito neointimal thickness. Journal of Vascular Surgery. 1999, 29(1): 157-167. Stress increases retention of endothelial cells on artificial vascular grafts and subsequently reduces neointimal thickness in vivo). The sheep carotid artery (Photofix) with an inner diameter of 4mm, through the action of the shear stress controlled by the researchers, makes the initial value of the shear stress value about 0.25dyn/cm 2 and the final value of about 1.2dyn/cm 2 , the action time is At 6 hours, 50% of the endothelial cells remained on Photofix (Carnagey J, Anderson DH, Ranieri J, et al. Rapid endothelialization of photofix natural biomaterial vascular grafts. J Biomed Mater Res Part B: Appl Biomater. 2003, 65B: .171 -179. The title is: rapid endothelialization of photofix natural artificial blood vessels). Although the shear stress values adopted by the former in these studies are somewhat random, and the number of shear stress values adopted is very limited, including only 1 or 25 dyn/cm 2 Normal shear stress values vary widely, but their results suggest that gradually increasing shear stress can increase cells' tolerance (resistance) to physiological levels of flow forces. What take in the present invention is the increasing shear stress of stepwise (stepwise), more emphasizes the gradual increase process of shear stress, and the shear stress value involved is in the range of the shear stress value suffered by normal human vascular endothelial cells, research The result has also confirmed that adopting the method of the present invention makes the human umbilical vein endothelial cells inoculated on the carotid artery of Wistar rats in which endothelial cells are removed pass through a stepwise increase, finally up to 26dyn/ cm After the shear stress acts for 24 hours, its retained area It is more than 80%. In 2002, Li Yuquan et al. reported that under a steady laminar shear stress of 40 dyn/cm 2 , the contents of fibronectin (Fn) and laminin (laminin, Ln) in the ECM of endothelial cells co-cultured with smooth muscle increased. This results in an increase in the adhesion and fluid shear stress resistance of endothelial cells. Philippe et al. used polyethylene terephthalate (polyethyleneterephthalate, PET) blood vessels (inner diameter 6 mm) in their experiments, and coated bovine collagen and low-density heparin on the inner surface, and cultured the adherent blood vessels using a pulsating perfusion system. For cells on grafts, the experimental results also show that long-term perfusion and high-level shear stress (equal to blood flow shear stress) are very conducive to the retention of planted endothelial cells on grafts.
(3)剪切力对内皮细胞应力纤维形成的影响:剪切力引起的EC的重排与EC细胞骨架的变化密切相关。细胞骨架由微丝、微管、中间纤维组成,其中肌动蛋白微丝(主要由纤维状肌动蛋白,F-actin组成)研究较多。陈槐卿在实验中除了发现流体剪切力作用的内皮细胞的被拉长,与流场方向一致外,同时也观察到了细胞内F-actin的排列方向也与切应力方向一致。早在1984年,Franke等就已经发现将培养的单层HUVEC在2dyne/cm2剪切力作用下,2-3小时后细胞中央形成了应力纤维,但是增加应力作用时间后,应力纤维无明显增加,细胞的形态仍然保持多角形。Dewey等也发现8dyne/cm2剪切力作用24h后内皮细胞中出现了应力纤维,此时的细胞形态也没有改变。我们的研究发现在流动状态下,培养的单层内皮细胞经10dyne/cm2作用24h后,细胞中央出现微丝形成的应力纤维,这一结果也说明了剪切力有诱导内皮细胞应力纤维形成的作用。在这些研究中,应力纤维虽然已经形成,但只是数量的增加,尚未形成粗大的微丝,这可能与切应力水平较低有关,我们通过增加剪切力的水平和长作用时间,发现细胞中央出现了非常显著的束状应力纤维,微丝的长度、厚度等都有明显的增加。这些实验说明了应力纤维的形成和增加的程度依赖于剪切力的大小和作用时间,也说明了在组织构建过程中需要用高水平和相对长时间的作用力来进行内皮细胞的动态培养。(3) The effect of shear stress on the formation of stress fibers in endothelial cells: The rearrangement of EC induced by shear stress is closely related to the change of EC cytoskeleton. The cytoskeleton is composed of microfilaments, microtubules, and intermediate fibers, among which actin microfilaments (mainly composed of fibrous actin and F-actin) have been studied more. In the experiment, Chen Huaiqing not only found that the endothelial cells were elongated by the fluid shear force, which was consistent with the direction of the flow field, but also observed that the arrangement direction of F-actin in the cells was also consistent with the direction of the shear stress. As early as 1984, Franke et al. have found that under the action of 2dyne/cm 2 shear force, the cultured monolayer HUVEC formed stress fibers in the center of the cells after 2-3 hours, but after increasing the stress time, the stress fibers were not obvious. increase, the shape of the cells remained polygonal. Dewey et al. also found that stress fibers appeared in endothelial cells after 8dyne/cm 2 shear force for 24 hours, and the cell morphology did not change at this time. Our research found that in the flow state, after the cultured monolayer endothelial cells were exposed to 10dyne/cm 2 for 24 hours, stress fibers formed by microfilaments appeared in the center of the cells. This result also shows that shear stress can induce the formation of stress fibers in endothelial cells role. In these studies, although the stress fibers have been formed, but only increased in number, and have not yet formed thick microfilaments, which may be related to the low level of shear stress. We found that the central Very significant bundle-like stress fibers appeared, and the length and thickness of microfilaments increased significantly. These experiments demonstrate that the degree of stress fiber formation and increase depends on the magnitude and duration of the shear force, and that high levels and relatively long periods of force are required for dynamic culture of endothelial cells during tissue building.
(4)剪切力对内皮细胞增殖的影响:研究者(Brian S.Conklin,M.S,et al.Shear StressRegulates Occludin and VEGF Expression in Porcine Arterial Endothelial Cells.Journal of Surgical Research.2002,102:13-21.题目为:剪应力调节了猪动脉内皮细胞的跨膜紧密连接蛋白和血管内皮细胞生长因子的表达)应用血管移植物灌流培养系统(15dyn/cm2和1.5dyn/cm2)为体外血管移植物(取自猪颈动脉)提供了生理条件下的压力和流动状态,使内皮细胞和平滑肌细胞得到了长期的存活。研究证明了低剪切力导致内皮细胞的增殖,上调内皮细胞VEGF的表达,而VEGF也促进内皮细胞增殖。(4) Effect of shear stress on endothelial cell proliferation: Brian S. Conklin, MS, et al. Shear Stress Regulates Occludin and VEGF Expression in Porcine Arterial Endothelial Cells. Journal of Surgical Research. .The title is: Shear stress regulates the expression of transmembrane tight junction protein and vascular endothelial cell growth factor of porcine arterial endothelial cells ) . The substance (taken from porcine carotid artery) provides pressure and flow state under physiological conditions, so that endothelial cells and smooth muscle cells can survive for a long time. Studies have demonstrated that low shear stress leads to proliferation of endothelial cells, up-regulates the expression of VEGF in endothelial cells, and VEGF also promotes proliferation of endothelial cells.
(5)剪切力对内皮细胞生理活性的影响:在分子生物学水平上,切变应力可上调c-fos,c-jun,c-myc等原癌基因mRNA水平,其基因产物作为转录激活因子或抑制因子结合于DNA启动子上的转录位点,调节基因表达。同时,切变应力可调节内皮素-1、组织纤溶酶原激活物(tPA)、血小板源性生长因子(PDGF)、粘附因子等目标基因mRNA水平。这些基因的表达产物对于重塑血管,调节细胞间、细胞和基质间的特异性吸附有重要作用。这些情况与体外静态培养的内皮细胞间存在着巨大的差异。高水平的剪切力还促进了内皮细胞释放细胞因子,这些因子能抑制凝血、白细胞的迁移和平滑肌细胞的增殖,而低水平的剪切力则起到了相反的作用。(5) The effect of shear stress on the physiological activity of endothelial cells: at the level of molecular biology, shear stress can up-regulate the mRNA levels of proto-oncogenes such as c-fos, c-jun, and c-myc, and their gene products act as transcriptional activators Factors or repressors bind to transcription sites on DNA promoters and regulate gene expression. At the same time, shear stress can regulate the mRNA levels of target genes such as endothelin-1, tissue plasminogen activator (tPA), platelet-derived growth factor (PDGF), and adhesion factors. The expression products of these genes play an important role in remodeling blood vessels and regulating the specific adsorption between cells and between cells and matrix. These conditions are quite different from those of endothelial cells cultured statically in vitro. High levels of shear stress also promote the release of cytokines from endothelial cells that inhibit coagulation, leukocyte migration, and smooth muscle cell proliferation, while low levels of shear stress have the opposite effect.
发明内容Contents of the invention
为了促进接种在人工血管内壁的内皮细胞粘附、为了提供粘附后内皮细胞耐受血流剪应力作用的能力,本发明提出一种在人工血管内表面种植内皮/内皮样细胞的方法,即采用生物力学的方法,通过体外的脉动的、阶梯式增加的流体剪应力作用,使内皮细胞更好地粘附在人工血管内壁,使粘附在人工血管内壁上的内皮细胞预先适应流体剪应力的作用,使得它在血管移植入体内后有更好的耐受血流剪应力作用的能力。In order to promote the adhesion of endothelial cells seeded on the inner wall of artificial blood vessels and to provide the ability of endothelial cells to withstand the shear stress of blood flow after adhesion, the present invention proposes a method for planting endothelial/endothelial-like cells on the inner surface of artificial blood vessels, namely Using biomechanical methods, through the pulsating and stepwise increasing fluid shear stress in vitro, the endothelial cells can better adhere to the inner wall of the artificial blood vessel, so that the endothelial cells adhered to the inner wall of the artificial blood vessel can adapt to the fluid shear stress in advance The effect makes it have a better ability to withstand the shear stress of blood flow after the blood vessel is transplanted into the body.
为达到上述目的,本发明采用了以下两种方法:方法一,在收集内皮细胞成细胞悬液后,接种在人工血管内表面,静态培养至细胞在人工血管内表面成融合状态后,施加脉动的、阶梯式增加的流体剪应力,直至达到在体时内皮细胞所受的剪应力值。在接种过程中,人工血管绕着其中轴线以一定的角速度转动。方法二,在收集内皮细胞成细胞悬液后,接种在人工血管内表面,同时开始施加脉动的、阶梯式增加的流体剪应力,直至达到在体时内皮细胞所受的剪应力值。在接种过程中,人工血管绕着其中轴线以一定的角速度转动。In order to achieve the above object, the present invention adopts the following two methods: method one, after collecting the endothelial cell suspension, inoculate it on the inner surface of the artificial blood vessel, culture it statically until the cells become confluent on the inner surface of the artificial blood vessel, and then apply pulsation The fluid shear stress increases stepwise until reaching the shear stress value of the endothelial cells in vivo. During the inoculation process, the artificial blood vessel rotates around its central axis at a certain angular velocity. Method 2: after collecting the endothelial cell suspension, inoculate it on the inner surface of the artificial blood vessel, and start to apply pulsating and stepwise fluid shear stress until the endothelial cell is subjected to the shear stress value in vivo. During the inoculation process, the artificial blood vessel rotates around its central axis at a certain angular velocity.
本发明中的人工血管可以为合成生物材料的,如涤纶(Dacron)、膨体聚四氟乙烯(e-PTFE)、聚氨酯(polyurethane,Pu)等,可以为天然生物材料的,如小肠粘膜下层、心包膜、筋膜、血管、或真皮等制成的无细胞基质。The artificial blood vessel in the present invention can be synthetic biological material, as dacron (Dacron), expanded polytetrafluoroethylene (e-PTFE), polyurethane (polyurethane, Pu) etc., can be natural biological material, as small intestine submucosa , pericardium, fascia, blood vessels, or acellular matrix made of dermis.
本发明方法的优点是通过脉动的、阶梯式增加的流体剪应力的作用,与现有的技术相比,本发明更强调流体剪应力的阶梯式加载过程,具有较匀速和逐渐增加的特点,之后,在达到在体所要求承受的剪应力值后,维持该值,直至进行动物实验等应用时才停止,剪应力的提供时间较长;所施加的剪应力是脉动的,接近于生理情况;而且本发明中涉及到的剪应力值范围处于正常人体的内皮细胞耐受范围,这样使得本发明方法制备人工血管具有潜在的临床应用价值;此外,本发明采用的内皮细胞可以是经过流体剪应力的驯化的,它在人工血管材料上具有更好的粘附性,这一点其他的研究者们是没有提到的。这样致使本发明在下列方面具有更大的优势:①使接种在人工血管内表面的内皮/内皮样细胞的细胞形态和排列情况接近于在体时的情况,即细胞伸长,顺流体方向排列;②增加内皮细胞在人工血管表面的粘附能力,从而使得人工血管在移植入体内后,能经受得了在体的血流剪应力的冲刷作用,而不致脱落;③诱导内皮/内皮样细胞应力纤维的形成;④抑制体外培养过程中内皮/内皮样细胞的过分增殖,使接种在人工血管内表面呈融合状态的内皮/内皮样细胞处于在体时的收缩表型;⑤使接种在人工血管内表面呈融合状态的内皮/内皮样细胞具有近似于在体的生理活性。这样达到对内皮细胞的逐渐驯化而增加其粘附性和生理活性的效果。The advantage of the method of the present invention is that by the action of the pulsating, stepwise increased fluid shear stress, compared with the prior art, the present invention puts more emphasis on the stepwise loading process of the fluid shear stress, and has the characteristics of a relatively uniform speed and gradual increase, After that, after reaching the required shear stress value in the body, maintain this value until the application such as animal experiments is stopped, and the shear stress is provided for a long time; the applied shear stress is pulsating, close to the physiological situation and the range of shear stress values involved in the present invention is in the endothelial cell tolerance range of normal human body, so that the method of the present invention prepares artificial blood vessels with potential clinical application value; Stress acclimation, it has better adhesion on artificial vascular materials, which other researchers did not mention. This causes the present invention to have greater advantages in the following aspects: 1. The cell morphology and arrangement of the endothelial/endothelial-like cells seeded on the inner surface of the artificial blood vessel are close to the situation in the body, that is, the cells are elongated and arranged in the direction of the fluid ; ②Increase the adhesion ability of endothelial cells on the surface of artificial blood vessels, so that after the artificial blood vessels are transplanted into the body, they can withstand the scouring effect of the blood flow shear stress in the body without falling off; ③Induce the stress of endothelial/endothelial-like cells The formation of fibers; ④ inhibit the excessive proliferation of endothelial/endothelial-like cells in the process of in vitro culture, so that the endothelial/endothelial-like cells inoculated on the inner surface of the artificial blood vessel in a confluent state are in the contraction phenotype in vivo; Endothelial/endothelial-like cells with a confluent inner surface have physiological activities similar to those in vivo. In this way, the effect of gradually acclimating endothelial cells and increasing their adhesion and physiological activity can be achieved.
采用本发明方法使得接种在去除内皮细胞的Wistar大鼠颈动脉上的人脐静脉内皮细胞通过最终高达26dyn/cm2的阶梯式增加的剪应力作用24小时后,其保留面积为80%以上。而在同样的实验条件下,采用15dyn/cm2的作用经2小时后,细胞之间出现明显的空缺区,其保留面积小于50%。Using the method of the present invention, the human umbilical vein endothelial cells inoculated on the carotid artery of Wistar rats from which endothelial cells have been removed are subjected to a stepwise increased shear stress of up to 26 dyn/ cm2 for 24 hours, and the retained area is more than 80%. However, under the same experimental conditions, after 2 hours with the action of 15 dyn/cm 2 , obvious gaps appeared between the cells, and the retained area was less than 50%.
图1接种在去除内皮细胞的Wistar大鼠颈动脉上的人脐静脉内皮细胞通过阶梯式增加的剪应力作用,剪应力从10dyn/cm2开始,阶梯为每3小时增加2dyn/cm2,脉动频率为40Hz,最终达到高达26dyn/cm2,血管绕其中轴旋转的速度为每小时120°,作用24小时后经过银染,在Olymus显微镜下的照片,放大倍数为80倍。照片中有较深颜色的线是细胞的膜被银染而成的,因此它表现的是细胞的轮廓,从照片中可以看出,细胞之间排列紧密。Figure 1 The human umbilical vein endothelial cells seeded on the carotid artery of Wistar rats with depleted endothelial cells were subjected to stepwise increasing shear stress. The shear stress started from 10dyn/cm 2 and increased by 2dyn/cm 2 every 3 hours, pulsating The frequency is 40Hz, and finally reaches as high as 26dyn/cm 2 . The speed of blood vessel rotation around its central axis is 120° per hour. After 24 hours of treatment, it is silver-stained. The magnification of the photo under the Olymus microscope is 80 times. The darker line in the photo is the membrane of the cell stained with silver, so it shows the outline of the cell. It can be seen from the photo that the cells are closely arranged.
图2接种在去除内皮细胞的Wistar大鼠颈动脉上的人脐静脉内皮细胞通过15dyn/cm2的剪应力作用2小时后经过银染,在Olymus显微镜下的照片,放大倍数为40倍。照片中有较深颜色的是细胞被银染而成的,从照片中可以看出,细胞之间有明显的空缺区。Fig. 2 The human umbilical vein endothelial cells inoculated on the carotid artery of Wistar rats from which the endothelial cells were removed were subjected to a shear stress of 15 dyn/cm 2 for 2 hours and then silver-stained. The photos under the Olymus microscope, the magnification is 40 times. The darker color in the photo is the cells stained with silver. It can be seen from the photo that there are obvious gaps between the cells.
附图说明Description of drawings
图1是通过本方法接种在去除内皮细胞的Wistar大鼠颈动脉上的人脐静脉内皮细胞的显微照片;Fig. 1 is a photomicrograph of human umbilical vein endothelial cells inoculated on the carotid artery of Wistar rats removing endothelial cells by this method;
图2是接种在去除内皮细胞的Wistar大鼠颈动脉上的人脐静脉内皮细胞通过15dyn/cm2的剪应力作用2小时后经过银染,在Olymus显微镜下的照片。Figure 2 is a photograph of human umbilical vein endothelial cells seeded on the carotid artery of Wistar rats from which endothelial cells have been removed, subjected to a shear stress of 15 dyn/cm 2 for 2 hours and then stained with silver under an Olymus microscope.
具体实施方式Detailed ways
例1、在去除细胞基质的鼠颈动脉血管移植材料上静态接种,之后施加阶梯式增加的流体剪应力,同时血管绕其中轴旋转培养内皮细胞Example 1. Static inoculation on murine carotid artery vascular graft material with cell matrix removed, followed by a stepwise increase in fluid shear stress, while the vessel was rotated around its central axis to cultivate endothelial cells
取经冷冻法去除内皮细胞的Wistar大鼠颈动脉,接种经过10dyns/cm2的剪应力驯化的兔原代动脉内皮细胞于内膜,接种方法如下:将经冷冻法去除内皮细胞的鼠颈动脉,内膜用PBS液清洗3次,将培养的原代兔内皮细胞用0.1%胰酶消化,收集细胞,细胞浓度约1×106cells/cm2,将收集的细胞接种到血管内膜,37℃,5%CO2培养箱静态培养约3天,待细胞融合成单层,然后,对接种的内皮细胞施加阶梯式增加的流体剪应力进行“驯化”,加载剪应力从10dyns/cm2开始,直至40dyns/cm2,阶梯为每隔3h增加5dyns/cm2,所需时间约12h,然后维持40dyns/cm2的剪应力,加载同时将人工血管以每半小时90°的角速度绕着其中轴线旋转,在37℃、5%CO2培养箱中培养。由此得到该发明的血管移植材料。Take the carotid artery of Wistar rats whose endothelial cells have been removed by freezing method, and inoculate rabbit primary arterial endothelial cells acclimated by a shear stress of 10 dyns/ cm2 in the intima. Wash the intima three times with PBS, digest the cultured primary rabbit endothelial cells with 0.1% trypsin, collect the cells, the cell concentration is about 1×10 6 cells/cm 2 , inoculate the collected cells into the vascular intima, 37 ℃, 5% CO 2 incubator for about 3 days, until the cells have fused into a single layer, then, apply a stepwise increase of fluid shear stress to the inoculated endothelial cells for "acclimation", and the loading shear stress starts from 10dyns/cm 2 , until 40dyns/cm 2 , the step is to increase 5dyns/cm 2 every 3h, the time required is about 12h, and then maintain the shear stress of 40dyns/cm 2 , while loading the artificial blood vessel around it at an angular velocity of 90° every half hour The axis was rotated and cultured in a 37°C, 5% CO 2 incubator. Thus, the vascular graft material of the invention was obtained.
例2、在去除细胞基质的鼠颈动脉血管移植材料上接种并同时施加阶梯式增加的流体剪应力,同时血管绕其中轴旋转培养内皮细胞Example 2. Inoculation on the mouse carotid artery vascular graft material with the cell matrix removed and simultaneously applying a stepwise increase in fluid shear stress, while the blood vessel was rotated around its central axis to cultivate endothelial cells
取经冷冻法去除内皮细胞的Wistar大鼠颈动脉,接种兔原代动脉内皮细胞于内膜,接种方法如下:将经冷冻法去除内皮细胞的鼠颈动脉,内膜用PBS液清洗3次,将培养的原代兔内皮细胞用0.1%胰酶消化,收集细胞,细胞浓度约1×106cells/cm2,将收集的细胞接种到血管内膜,同时对内皮细胞施加阶梯式增加的流体剪应力,加载剪应力起始值约为5dyns/cm2,阶梯为每隔1h增加0.1dyns/cm2,所需时间约12h,再变化阶梯为每隔1h增加1.0dyns/cm2加载时间约12h,加载同时将人工血管以每半小时90°的角速度绕着其中轴线旋转,在37℃、5%CO2培养箱中培养。由此得到该发明的血管移植材料。Take the carotid artery of Wistar rats whose endothelial cells were removed by freezing method, and inoculate rabbit primary arterial endothelial cells on the intima. The cultured primary rabbit endothelial cells were digested with 0.1% trypsin, and the cells were collected at a concentration of about 1×10 6 cells/cm 2 . The collected cells were inoculated into the intima of blood vessels, and at the same time, a stepwise increase of fluid shear was applied to the endothelial cells. Stress, the initial value of loading shear stress is about 5dyns/cm 2 , the step is to increase 0.1dyns/cm 2 every 1h, the required time is about 12h, and then change the step to increase 1.0dyns/cm 2 every 1h, the loading time is about 12h , while loading, the artificial blood vessel was rotated around its central axis at an angular velocity of 90° every half hour, and cultured in a 37°C, 5% CO 2 incubator. Thus, the vascular graft material of the invention was obtained.
例3、在去除细胞基质的山羊颈动脉血管移植材料上接种并同时施加脉动的、阶梯式增加的流体剪应力,同时血管绕其中轴旋转培养内皮细胞Example 3. Inoculation and simultaneous application of pulsating, step-wise increasing fluid shear stress on goat carotid artery graft material without cell matrix, while the vessel rotates around its central axis to cultivate endothelial cells
取经酶消化法去除内皮细胞的山羊颈动脉,接种原代培养的人脐静脉内皮细胞于内膜,接种方法如下:取经酶消化法去除内皮细胞的山羊颈动脉,内膜用PBS液清洗3次,将培养的原代人脐静脉内皮细胞用0.1%胰酶消化,收集细胞,细胞浓度约1×106cells/cm2,将收集的细胞接种到血管内膜,同时对内皮细胞施加脉动的、阶梯式增加的流体剪应力,脉动频率为80Hz,加载剪应力起始值约为5dyns/cm2,阶梯为每隔1h增加0.3dyns/cm2,所需时间约12h,再变化阶梯为每隔1h增加10dyns/cm2,加载时间约4h,之后维持约50dyns/cm2的剪应力,加载同时将人工血管以每分钟20°的角速度绕着其中轴线旋转,在37℃、5%CO2培养箱中培养。由此得到该发明的血管移植材料。Take the goat carotid artery from which endothelial cells have been removed by enzymatic digestion, and inoculate the primary cultured human umbilical vein endothelial cells on the intima. , the cultured primary human umbilical vein endothelial cells were digested with 0.1% trypsin, and the cells were collected at a concentration of about 1×10 6 cells/cm 2 . The collected cells were inoculated into the intima of the blood vessel, and pulsating pressure was applied to the endothelial cells at the same time. 1. The fluid shear stress increases stepwise, the pulsation frequency is 80Hz, the initial value of the loaded shear stress is about 5dyns/cm 2 , the step is to increase 0.3dyns/cm 2 every 1h, the time required is about 12h, and then the step is changed to every Increase 10 dyns/cm 2 every 1 hour, load for about 4 hours, and then maintain a shear stress of about 50 dyns/cm 2 , load while rotating the artificial blood vessel around its central axis at an angular velocity of 20° per minute, at 37°C, 5% CO 2 cultured in an incubator. Thus, the vascular graft material of the invention was obtained.
例4、在膨体聚四氟乙烯(ePTFE)血管材料上静态接种,之后施加脉动的、阶梯式增加的流体剪应力,同时血管绕其中轴旋转培养的内皮细胞Example 4. Cultured endothelial cells statically seeded on expanded polytetrafluoroethylene (ePTFE) vascular material followed by application of pulsatile, step-wise increasing fluid shear stress while the vessel rotates about its central axis
将膨体聚四氟乙烯(ePTFE)血管支架材料灭菌处理后,取一段(内径约1.5mm,长约4-5cm),接种经5-10dyns/cm2流体剪应力驯化的兔原代动脉内皮细胞于内膜,接种方法如下:将膨体聚四氟乙烯(ePTFE)血管支架材料的内膜用PBS液清洗3次,并预衬纤维粘连蛋白(FN)后,将培养的原代兔内皮细胞用0.1%胰酶消化,收集细胞,细胞浓度约1×106cells/cm2,将收集的细胞接种到血管内膜,37℃,5%CO2培养箱静态培养约3天,待细胞融合成单层后,施加脉动的、阶梯式增加的流体剪应力进行“驯化”,脉动频率为150Hz,加载剪应力从2dyns/cm2开始,直至20dyns/cm2,阶梯为每隔1h增加1dyns/cm2,所需时间约18h,然后维持20dyns/cm2的剪应力,加载同时将人工血管以每小时300°的角速度绕着其中轴线旋转,在37℃、5%CO2培养箱中培养。由此得到该发明的血管移植材料。After sterilizing the expanded polytetrafluoroethylene (ePTFE) vascular stent material, take a section (about 1.5mm in inner diameter, about 4-5cm in length) and inoculate rabbit primary arteries acclimated by fluid shear stress of 5-10dyns/ cm2 The endothelial cells were inoculated in the intima, and the inoculation method was as follows: the intima of the expanded polytetrafluoroethylene (ePTFE) vascular stent material was washed three times with PBS, and after pre-lined with fibronectin (FN), the cultured primary rabbit Endothelial cells were digested with 0.1% trypsin, and the cells were collected at a concentration of about 1×10 6 cells/cm 2 . The collected cells were inoculated into the intima of blood vessels, and cultured statically for about 3 days in a 5% CO 2 incubator at 37°C. After the cells have fused into a single layer, apply pulsating, stepwise increasing fluid shear stress for "acclimation", the pulsating frequency is 150Hz, and the loading shear stress starts from 2dyns/cm 2 to 20dyns/cm 2 , and the step increases every 1h 1dyns/cm 2 , the required time is about 18h, and then maintain a shear stress of 20dyns/cm 2 , while loading, the artificial blood vessel is rotated around its central axis at an angular velocity of 300° per hour, in a 37°C, 5% CO 2 incubator nourish. Thus, the vascular graft material of the invention was obtained.
例5、在聚氨酯(polyurethane,Pu)血管材料上接种并同时施加脉动的、阶梯式增加的流体剪应力,同时血管绕其中轴旋转培养内皮细胞Example 5. Seeding on polyurethane (polyurethane, Pu) vascular material and simultaneously applying pulsating, stepwise increased fluid shear stress, while the blood vessel rotates around its central axis to cultivate endothelial cells
将聚氨酯(polyurethane,Pu)血管材料灭菌处理后,取一段(内径约2mm,长约4-5cm),接种经5-10dyns/cm2流体剪应力驯化的人原代动脉内皮细胞于内膜,接种方法如下:将经聚氨酯血管支架材料的内膜用PBS液清洗3次,并预衬玻璃粘连蛋白(LN)后,将培养的原代人脐静脉内皮细胞用0.1%胰酶消化,收集细胞,细胞浓度约1×10u6cells/cm2,将收集的细胞接种到血管内膜,同时对内皮细胞施加脉动的、阶梯式增加的流体剪应力,脉动频率为40Hz,加载剪应力起始值约为2dyns/cm2,阶梯为每隔1h增加0.2dyns/cm2,所需时间约12h,再变化阶梯为每隔1h增加5dyns/cm2,加载时间约5h,之后维持约35dyns/cm2的剪应力,加载同时将人工血管以每分钟10°的角速度绕着其中轴线旋转,在37℃、5%CO2培养箱中培养。由此得到该发明的血管移植材料。After sterilizing the polyurethane (Pu) vascular material, take a section (about 2mm in inner diameter and about 4-5cm in length) and inoculate the intima with human primary arterial endothelial cells acclimated by fluid shear stress of 5-10dyns/ cm2 , the inoculation method was as follows: the intima of the polyurethane stent material was washed 3 times with PBS, and pre-lined with vitronectin (LN), the cultured primary human umbilical vein endothelial cells were digested with 0.1% trypsin, collected Cells, the cell concentration is about 1×10u 6 cells/cm 2 , the collected cells are inoculated into the intima of the blood vessel, and at the same time, a pulsating, stepwise increasing fluid shear stress is applied to the endothelial cells, the pulsation frequency is 40Hz, and the initial shear stress is The value is about 2dyns/cm 2 , the step is to increase 0.2dyns/cm 2 every 1h, the time required is about 12h, and then change the step to increase 5dyns/cm 2 every 1h, the loading time is about 5h, and then maintain about 35dyns/cm 2 shear stress, while loading the artificial blood vessel at an angular velocity of 10° per minute around its central axis, culture it in a 37°C, 5% CO 2 incubator. Thus, the vascular graft material of the invention was obtained.
例6、在去除细胞基质的山羊颈动脉血管移植材料上接种并同时施加脉动的、阶梯式增加的流体剪应力,同时血管绕其中轴旋转培养内皮细胞Example 6. Inoculation of goat carotid artery vascular graft material without cell matrix and simultaneous application of pulsating, step-wise increasing fluid shear stress, while the vessel rotates around its central axis to cultivate endothelial cells
取经酶消化法去除内皮细胞的山羊颈动脉,接种原代培养的人脐静脉内皮细胞于内膜,接种方法如下:将经酶消化法去除内皮细胞的山羊颈动脉血管移植材料内膜用PBS液清洗3次,将培养的原代人脐静脉内皮细胞用0.1%胰酶消化,收集细胞,细胞浓度约1×106cells/cm2,将收集的细胞接种到血管内膜,同时对内皮细胞施加脉动的、阶梯式增加的流体剪应力,脉动频率为60Hz,加载剪应力起始值约为10dyns/cm2,阶梯为每隔1h增加0.3dyns/cm2,所需时间约12h,再变化阶梯为每隔1h增加3dyns/cm2,加载时间约10h,之后维持约45dyns/cm2的剪应力,加载同时将人工血管以每分钟5°的角速度绕着其中轴线旋转,在37℃、5%CO2培养箱中培养。由此得到该发明的血管移植材料。Take the goat carotid artery from which endothelial cells have been removed by enzymatic digestion, and inoculate primary cultured human umbilical vein endothelial cells on the intima. Wash 3 times, digest the cultured primary human umbilical vein endothelial cells with 0.1% trypsin, collect the cells, the cell concentration is about 1×10 6 cells/cm 2 , inoculate the collected cells into the vascular intima, and at the same time, treat the endothelial cells Apply pulsating, step-wise increasing fluid shear stress, the pulsation frequency is 60Hz, the initial value of loading shear stress is about 10dyns/cm 2 , the step is to increase 0.3dyns/cm 2 every 1h, the time required is about 12h, and then change The step is to increase 3 dyns/cm 2 every 1 h, the loading time is about 10 h, and then maintain a shear stress of about 45 dyns/cm 2 , while loading, the artificial blood vessel is rotated around its central axis at an angular speed of 5° per minute, at 37°C, 5 %CO 2 incubator. Thus, the vascular graft material of the invention was obtained.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100218756A CN100340220C (en) | 2004-02-19 | 2004-02-19 | Method for planting esoderma/endothelial cell on inner surface of artificial blood vessel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100218756A CN100340220C (en) | 2004-02-19 | 2004-02-19 | Method for planting esoderma/endothelial cell on inner surface of artificial blood vessel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1559360A CN1559360A (en) | 2005-01-05 |
| CN100340220C true CN100340220C (en) | 2007-10-03 |
Family
ID=34440888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100218756A Expired - Fee Related CN100340220C (en) | 2004-02-19 | 2004-02-19 | Method for planting esoderma/endothelial cell on inner surface of artificial blood vessel |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100340220C (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100431504C (en) * | 2005-05-09 | 2008-11-12 | 北京中孵友信医药科技有限公司 | Cell coated stent |
| US20160178491A1 (en) | 2014-12-22 | 2016-06-23 | Saint-Gobain Performance Plastics Corporation | Capture system of cells and methods |
| CN104758980B (en) * | 2015-02-03 | 2018-02-09 | 北京航空航天大学 | A kind of method that external structure has the intravascular cortex of anti-Osima jacoti, Osima excavata and anti-platelet aggregation function |
| CN105268025B (en) * | 2015-10-15 | 2018-07-03 | 盐城工业职业技术学院 | A kind of preparation method of silk-fibroin cell composite vascular stent |
| CN107456296B (en) * | 2016-09-14 | 2020-07-14 | 四川蓝光英诺生物科技股份有限公司 | Lumen tissue construct, method and device for producing lumen tissue construct |
| CN107411845A (en) * | 2016-09-14 | 2017-12-01 | 四川蓝光英诺生物科技股份有限公司 | Lumen organization's construct, lumen organization's structure preparation and its device |
| CN107308495A (en) * | 2017-07-06 | 2017-11-03 | 苏州期佰生物技术有限公司 | A kind of artificial blood vessel based on trees-Osima jacoti, Osima excavata and preparation method thereof |
| CN110327030A (en) * | 2019-04-16 | 2019-10-15 | 南方医科大学珠江医院 | Simulate experimental model and its application of coronary artery bridge vascular flow state |
| CN112608882B (en) * | 2021-01-14 | 2022-11-18 | 大连理工大学 | Method for manufacturing silica gel blood vessel model planted with endothelial cells |
| CN116617460B (en) * | 2023-05-29 | 2024-06-11 | 中国人民解放军陆军军医大学 | In-vitro endothelialized vascular implant, and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993001843A1 (en) * | 1991-07-25 | 1993-02-04 | University Of Leicester | Preparing grafts for implantation |
| US5792603A (en) * | 1995-04-27 | 1998-08-11 | Advanced Tissue Sciences, Inc. | Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts |
| US5843781A (en) * | 1993-04-28 | 1998-12-01 | The Johns Hopkins University School Of Medicine | Implantable prosthetic vascular device having an adherent cell monolayer produced under shear stress |
-
2004
- 2004-02-19 CN CNB2004100218756A patent/CN100340220C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993001843A1 (en) * | 1991-07-25 | 1993-02-04 | University Of Leicester | Preparing grafts for implantation |
| US5843781A (en) * | 1993-04-28 | 1998-12-01 | The Johns Hopkins University School Of Medicine | Implantable prosthetic vascular device having an adherent cell monolayer produced under shear stress |
| US5792603A (en) * | 1995-04-27 | 1998-08-11 | Advanced Tissue Sciences, Inc. | Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1559360A (en) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pawlowski et al. | Endothelial cell seeding of polymeric vascular grafts | |
| CN101066477B (en) | Biological artificial blood vessel capable of in vivo capturing endothelial ancestral cell | |
| Isenberg et al. | Small-diameter artificial arteries engineered in vitro | |
| Kannan et al. | The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review | |
| CN111714706B (en) | Vascular stent capable of promoting vascular cell proliferation and secreting extracellular matrix, preparation method of vascular stent and active artificial blood vessel | |
| Kakisis et al. | Artificial blood vessel: the Holy Grail of peripheral vascular surgery | |
| Shaikh et al. | Fibrin: a natural biodegradable scaffold in vascular tissue engineering | |
| USRE42479E1 (en) | Engineering of strong, pliable tissues | |
| Bader et al. | Tissue engineering of heart valves–human endothelial cell seeding of detergent acellularized porcine valves | |
| Mitchell et al. | Requirements for growing tissue-engineered vascular grafts | |
| Saito et al. | Challenges and possibilities of cell-based tissue-engineered vascular grafts | |
| Isenberg et al. | Building structure into engineered tissues | |
| WO2002040630A2 (en) | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering | |
| JP2002527191A (en) | Cardiovascular component for transplantation and method of manufacturing the same | |
| JP2011519616A (en) | Blood vessels by tissue engineering | |
| CN100340220C (en) | Method for planting esoderma/endothelial cell on inner surface of artificial blood vessel | |
| Klopsch et al. | Tissue-engineered devices in cardiovascular surgery | |
| JP2002531118A (en) | Applying shear flow stress to smooth muscle cells to produce implantable structures | |
| CN101094697B (en) | Engineering with homing factors | |
| Hsia et al. | Scaffolds and cell-based tissue engineering for blood vessel therapy | |
| CN104758980B (en) | A kind of method that external structure has the intravascular cortex of anti-Osima jacoti, Osima excavata and anti-platelet aggregation function | |
| Arrigoni et al. | Vascular tissue engineering | |
| LEE et al. | Endothelial cell seeding onto the extracellular matrix of fibroblasts for the development of a small diameter polyurethane vessel | |
| Mian et al. | Stimulating effect of an arteriovenous shunt on the in vivo growth of isografted fibroblasts: a preliminary report | |
| CN107715179B (en) | Composite artificial small blood vessel stent and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071003 |